Coping with the mental health impact of COVID-19: A study protocol for a multinational longitudinal study on coping and resilience during the COVID-19 pandemic.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
30
01
2023
accepted:
01
05
2023
medline:
22
5
2023
pubmed:
18
5
2023
entrez:
18
5
2023
Statut:
epublish
Résumé
Mental health is challenged due to serious life events such as the COVID-19 pandemic and can differ by the level of resilience. National studies on mental health and resilience of individuals and communities during the pandemic provide heterogeneous results and more data on mental health outcomes and resilience trajectories are needed to better understand the impact of the pandemic on mental health in Europe. COPERS (Coping with COVID-19 with Resilience Study) is an observational multinational longitudinal study conducted in eight European countries (Albania, Belgium, Germany, Italy, Lithuania, Romania, Serbia, and Slovenia). Recruitment of participants is based on convenience sampling and data are gathered through an online questionnaire. gathering data on depression, anxiety, stress-related symptoms suicidal ideation and resilience. Resilience is measured with the Brief Resilience Scale and with the Connor-Davidson Resilience Scale. Depression is measured with the Patient Health Questionnaire, Anxiety with the Generalized Anxiety Disorder Scale and stress-related symptoms with the Impact of Event Scale Revised- Suicidal ideation is assessed using item 9 of the PHQ-9. We also consider potential determinants and moderating factors for mental health conditions, including sociodemographic characteristics (e.g., age, gender), social environmental factors (e.g., loneliness, social capital) and coping strategies (e.g., Self-efficacy Belief). To the best of our knowledge, this is the first study to multi-nationally and longitudinally determine mental health outcomes and resilience trajectories in Europe during the COVID-19 pandemic. The results of this study will help to determine mental health conditions during the COVID-19 pandemic across Europe. The findings may benefit pandemic preparedness planning and future evidence-based mental health policies.
Sections du résumé
BACKGROUND
Mental health is challenged due to serious life events such as the COVID-19 pandemic and can differ by the level of resilience. National studies on mental health and resilience of individuals and communities during the pandemic provide heterogeneous results and more data on mental health outcomes and resilience trajectories are needed to better understand the impact of the pandemic on mental health in Europe.
METHODS
COPERS (Coping with COVID-19 with Resilience Study) is an observational multinational longitudinal study conducted in eight European countries (Albania, Belgium, Germany, Italy, Lithuania, Romania, Serbia, and Slovenia). Recruitment of participants is based on convenience sampling and data are gathered through an online questionnaire. gathering data on depression, anxiety, stress-related symptoms suicidal ideation and resilience. Resilience is measured with the Brief Resilience Scale and with the Connor-Davidson Resilience Scale. Depression is measured with the Patient Health Questionnaire, Anxiety with the Generalized Anxiety Disorder Scale and stress-related symptoms with the Impact of Event Scale Revised- Suicidal ideation is assessed using item 9 of the PHQ-9. We also consider potential determinants and moderating factors for mental health conditions, including sociodemographic characteristics (e.g., age, gender), social environmental factors (e.g., loneliness, social capital) and coping strategies (e.g., Self-efficacy Belief).
DISCUSSION
To the best of our knowledge, this is the first study to multi-nationally and longitudinally determine mental health outcomes and resilience trajectories in Europe during the COVID-19 pandemic. The results of this study will help to determine mental health conditions during the COVID-19 pandemic across Europe. The findings may benefit pandemic preparedness planning and future evidence-based mental health policies.
Identifiants
pubmed: 37200282
doi: 10.1371/journal.pone.0285803
pii: PONE-D-23-00090
pmc: PMC10194934
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0285803Informations de copyright
Copyright: © 2023 Backhaus et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors declared that no competing interests exist.
Références
J Affect Disord. 2021 Mar 15;283:156-164
pubmed: 33556749
J Adolesc Health. 2021 Jan;68(1):53-56
pubmed: 33183926
Confl Health. 2014 Aug 20;8:13
pubmed: 25177360
J Health Monit. 2020 Oct 09;5(Suppl 7):3-17
pubmed: 35146298
Int J Methods Psychiatr Res. 2006 Jun;15(2):95-103
pubmed: 19722290
PLoS One. 2012;7(12):e52028
pubmed: 23251676
Int J Behav Med. 2008;15(3):194-200
pubmed: 18696313
J Affect Disord. 2017 Jun;215:77-84
pubmed: 28319695
Alcohol Clin Exp Res. 2005 May;29(5):844-54
pubmed: 15897730
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1049-1057
pubmed: 32790653
Advers Resil Sci. 2020;1(2):95-106
pubmed: 32838305
Psychiatry Res. 2020 Jun;288:112954
pubmed: 32325383
Soc Sci Med. 2013 Jun;86:96-102
pubmed: 23608098
Arch Psychiatr Nurs. 2021 Aug;35(4):375-394
pubmed: 34176579
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Dev Psychopathol. 2012 Nov;24(4):1297-306
pubmed: 23062298
BMJ. 2019 Apr 9;365:l1476
pubmed: 30967483
Am J Epidemiol. 2020 Nov 2;189(11):1369-1378
pubmed: 32406501
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Dtsch Arztebl Int. 2018 Sep 21;115(38):621-627
pubmed: 30373706
Psychiatry Res. 2020 Sep;291:113216
pubmed: 32544705
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Lancet Reg Health Eur. 2021 Mar;2:100020
pubmed: 33870246
Psychol Sci. 2006 Mar;17(3):181-6
pubmed: 16507055
Int J Environ Res Public Health. 2021 Mar 26;18(7):
pubmed: 33810225
J Affect Disord. 2021 Dec 1;295:771-780
pubmed: 34517251
Eur J Psychotraumatol. 2014 Oct 01;5:
pubmed: 25317257
Depress Anxiety. 2003;18(2):76-82
pubmed: 12964174
Front Psychiatry. 2021 Mar 08;12:635832
pubmed: 33762980
J Epidemiol Community Health. 2020 Nov;74(11):964-968
pubmed: 32535550
Lancet Psychiatry. 2020 Oct;7(10):883-892
pubmed: 32707037
PLoS One. 2021 Aug 18;16(8):e0256041
pubmed: 34407127
Riv Psichiatr. 2015 Mar-Apr;50(2):89-94
pubmed: 25994619
J Pers Soc Psychol. 1980 Sep;39(3):472-80
pubmed: 7431205